Prevalence and predictors of depression treatment in an international primary care study

American Journal of Psychiatry

Volumn 161, Issue 9, 2004, Pages 1626-1634

  Simon, Gregory E ^a   Fleck, Marcelo ^b   Lucas, Ramona ^b   Bushnell, Donald M ^b  

^a CENTER FOR HEALTH STUDIES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOFEN; ALTROLAT; AMFEBUTAMONE; AMITRIPTYLINE; AMOXAPINE; ANTIDEPRESSANT AGENT; AREMIS; BENZODIAZEPINE DERIVATIVE; BESITRAN; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOSULEPIN; DOXEPIN; ELATROLET; ESKALITH CR; EUFOR; FAVOXIL; FLUOXETINE; FLUTINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; FLUXETINE; IMIPRAMINE; ISOCARBOXAZID; LICARBIUM; LITHIUM; LITHIUM CARBONATE; LOFEPRAMINE; MAPROTILINE; MARONIL; MIANSERIN; MOCLOBEMIDE; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; PHENELZINE; PRISDAL; PRIZMA; PRODEP; PROTRIPTYLINE; RENEURON; SERTRALINE; TIANEPTINE; TOFRANIL PM; TRANYLCYPROMINE; TRAZODONE; TRIMIPRAMINE; TRIPTAFEN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VENLAFAXINE; VEROTINA; VILOXAZINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEPRESSION; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE FACILITY; HEALTH CARE UTILIZATION; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MENTAL HEALTH CARE; MENTAL HEALTH SERVICE; PREDICTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; SCREENING;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; CROSS-CULTURAL COMPARISON; DEPRESSIVE DISORDER; DRUG COSTS; DRUG UTILIZATION; FEMALE; HEALTH CARE SURVEYS; HUMANS; LONGITUDINAL STUDIES; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; PRIMARY HEALTH CARE; PSYCHIATRIC STATUS RATING SCALES;

EID: 4444297477     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.161.9.1626     Document Type: Article

References (40)

1. Goldman L, Nielsen N, Champion H: Awareness, diagnosis, and treatment of depression. J Gen Intern Med 1999; 14:569-580
2. Hirschfeld R, Keller MB, Panico S, Arons BS, Barlow D, Davidoff F, Endicott J, Froom J, Goldstein M, Gorman JM, Guthrie D, Marek RS, Maurer TA, Meyer R, Phillips K, Ross J, Schwenk TL, Sharfstein SS, Thase ME, Wyatt RJ: The National Depressive and Manic-Depressive Association Consensus Statement on the Undertreatment of Depression. JAMA 1997; 277:333-340
3. Young A, Klapp R, Sherbourne C, Wells K: The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry 2001; 58:55-61
4. Simon G, Goldberg D, Tiemens B, Ustun T: Outcomes of recognized and unrecognized depression in an international primary care study. Gen Hosp Psychiatry 1999; 21:97-105
5. Goldberg D, Privett M, Ustun T, Simon G, Linden M: The effects of detection and treatment on the outcome of major depression in primary care: a naturalistic study in 15 cities. Br J Gen Pract 1998; 48:1840-1844
6. Simon G, Von Korff M, Rutter C, Peterson D: Treatment process and outcomes for managed care patients receiving new antidepressant prescriptions from psychiatrists and primary care physicians. Arch Gen Psychiatry 2001; 58:395-401
7. Linden M, Lecrubier Y, Bellantuono C, Benkert O, Kisely S, Simon G: The prescribing of psychotropic drugs by primary care physicians: an international collaborative study. J Clin Psychopharmacol 1999; 19:132-140
8. Kisely S, Linden M, Bellantuono C, Simon G, Jones J: Why are patients prescribed psychotropic drugs by general practitioners? results of an international study. Psychol Med 2000; 30:1217-1225
9. Sclar D, Robinson L, Skaer T, Galin R: What factors influence the prescribing of antidepressant pharmacotherapy? an assessment of national office-based encounters. Int J Psychiatry Med 1998; 28:407-419
10. Cornwell J, Hull S: Do GPs prescribe antidepressants differently for South Asian patients? Fam Pract 1998; 15(suppl 1):S16-S18
11. Skaer T, Sclar D, Robinson L, Galin R: Trends in the rate of depressive illness and use of antidepressant pharmacotherapy by ethnicity/race: an assessment of office-based visits in the United States, 1992-1997. Clin Ther 2000; 22:1575-1589
12. Blazer DG, Hybels CF, Simonsick EM, Hanlon JT: Marked differences in antidepressant use by race in an elderly community sample: 1986-1996. Am J Psychiatry 2000; 157:1089-1094
13. Pharoah P, Melzer D: Variation in prescribing of hypnotics, anxiolytics, and antidepressants between 61 general practices. Br J Gen Pract 1995; 45:595-599
14. Hull S, Cornwell JHC, Eldridge S, Bare P: Prescribing rates for psychotropic medication among East London general practices. Fam Pract 2001; 18:167-173
15. Ornstein S, Stuart G, Jenkins R: Depression diagnoses and antidepressant use in primary care practices: a study from the Practice Partner Research Network. J Fam Pract 2000; 49:68-72
16. Main D, Lutz L, Barrett J, Matthew J, Miller R: The role of primary care clinician attitudes, beliefs, and training in the diagnosis and treatment of depression. Arch Fam Med 1993; 2: 1061-1066
17. Ustun T, VonKorff M: Primary mental health services: access and provision of care, in Mental Illness in General Health Care: An International Study. Edited by Ustun T, Sartorius N. New York, John Wiley & Sons, 1995, pp 347-360
18. Melfi C, Croghan T, Hanna M: Access to treatment for depression in a Medicaid population. J Health Care Poor Underserved 1999; 10:201-215
19. Simon GE, Grothaus L, Durham ML, VonKorff M, Pabiniak C: Impact of visit copayments on outpatient mental health utilization by members of a health maintenance organization. Am J Psychiatry 1996; 153:331-338
20. Landerman LR, Burns BJ, Swartz MS, Wagner HR, George LK: The relationship between insurance coverage and psychiatric disorder in predicting use of mental health services. Am J Psychiatry 1994; 151:1785-1790
21. Chisholm D, Amir M, Fleck M, Hermann H, Lomachenlov A, Lucas R, Patrick D: Longitudinal investigation of depression outcomes (the LIDO Study) in primary care in six countries: comparative assessment of local health systems and resource utilization. Int J Methods Psychiatr Res 2001; 10:59-71
22. American Psychiatric Association: Practice Guideline for the Treatment of Patients With Bipolar Disorder (Revision). Am J Psychiatry 2002; 159(April suppl)
23. Herman H, Patrick DL, Diehr P, Martin ML, Fleck M, Simon GE, Buesching DP: Longitudinal investigation of depression outcomes in primary care in six countries: the LIDO Study: functional status, health service use, and treatment of people with depressive symptoms. Psychol Med 2002; 32:889-902
24. Radloff LS: The CES-D Scale: a self-report depression scale for research in the general population. J Applied Psychol Measurement 1977; 1:385-401
25. Ware J, Kosinski M, Keller S: SF-12-How to score the SF-12 Physical and Mental Health Summary Scales, 2nd ed. Boston, New England Medical Center, Health Institute, 1995
26. Mulrow C, Williams J, Gerrity M, Ramirez B, Montiel O: Case-finding instruments for depression in primary care settings. Ann Intern Med 1995; 122:913-921
27. Robins LN, Wing J, Wittchen HU, Helzer JE, Babor TF, Burke J, Farmer A, Jablenski A, Pickens R, Regier DA, Sartorius N, Towle LH: The Composite International Diagnostic Interview: an epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry 1988; 45:1069-1077
28. Derogatis L, Rickels K, Uhlenhuth EH, Covi L: The Hopkins Symptom Checklist: a measure of primary symptom dimensions, in Psychological Measurements in Psychopharmacology: Modern Problems in Pharmacopsychiatry, vol 7. Edited by Pichot P, Olivier-Martin R. Basel, Switzerland, S Karger, 1974, pp 79-110
29. Babor T, delaFuente J, Saunders J, Grant M: AUDIT: The Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Care. Geneva, World Health Organization, 1989
30. Chisholm D, Knapp M, Knudsen H, Ammadeo F, Gaite L, Van Wijngaarden B (Epsilon Group): The Client Socio-Demographic and Service Receipt Inventory (CSSRI-EU): development of an instrument for international research. Br J Psychiatry 2000; 176(suppl 39):S28-S33
31. Depression Guideline Panel: Depression in Primary Care, vol 2: Treatment of Major Depression: Clinical Practice Guideline Number 5: AHCPR Publication 93-0550. Rockville, Md, US Department of Health and Human Services, Agency for Health Policy and Research, 1993
32. Mynors-Wallis L, Gath DH, Lloyd-Thomas AR, Tomlinson D: Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care. BMJ 1995; 310:441-445
33. Katon W, Robinson P, VonKorff M, Lin E, Bush T, Ludman E, Simon G, Walker E: A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry 1996; 53:924-932
34. Harlow S, Linet MS: Agreement between questionnaire data and medical records: the evidence for accuracy of recall. Am J Epidemiol 1989; 129:233-248
35. Sturm R: Instrumental variable methods for effectiveness research. Int J Methods Psychiatr Res 1999; 7:17-26
36. Callahan CM, Hendrie HC, Dittus RS, Brater DC, Hui SL, Tierney WM: Improving treatment of late life depression in primary care: a randomized clinical trial. J Am Geriatr Soc 1994; 42: 839-846
37. Dowrick C, Buchan I: Twelve month outcome of depression in general practice: does detection or disclosure make a difference? BMJ 1995; 311:1274-1277
38. Whooley M, Stone B, Soghikian K: Randomized trial of case-finding for depression in elderly primary care patients. J Gen Intern Med 2000; 15:293-300
39. Wells KB, Katon W, Rogers B, Camp P: Use of minor tranquilizers and antidepressant medications by depressed outpatients: results from the Medical Outcomes Study. Am J Psychiatry 1994; 151:694-700
40. Simon G, VonKorff M, Piccinelli M, Fullerton C, Ormel J: An international study of the relation between somatic symptoms and depression. N Engl J Med 1999; 341:1329-1335